Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-30 @ 4:31 AM
Study NCT ID:
NCT01275157
Status:
COMPLETED
Last Update Posted:
2011-04-15
First Post:
2011-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Disposition of 14C-LY2452473 Following Oral Administration in Healthy Human Subjects
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
Disposition of [14C]-LY2452473 Following Oral Administration in Healthy Human Subjects
Status:
COMPLETED
Status Verified Date:
2011-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a single dose study of radiolabeled \[14C\]-LY2452473 in healthy male volunteers to study the absorption, distribution, metabolism, and elimination of LY2452473.
This study is for research purposes only and is not intended to treat any medical condition.
This study is for research purposes only and is not intended to treat any medical condition.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| I2N-MC-GPBF | OTHER | Eli Lilly and Company | View |